Skip to content
2000
Volume 9, Issue 5
  • ISSN: 1871-5281
  • E-ISSN: 2212-4055

Abstract

Even though there is a strong evidence suggestive of benefits and safety of dual (aspirin plus clopidogrel) antiplatelet therapy, decreased responsiveness or “resistance” to mono- and/or dual antiplatelet therapy has been described in association with an increased thrombotic risk. Various mechanisms contribute to antiplatelet resistance, with abundant production of inflammatory markers being of particular importance. The current review overviews implications of inflammation in antiplatelet resistance.

Loading

Article metrics loading...

/content/journals/iadt/10.2174/187152810793938017
2010-12-01
2025-09-07
Loading full text...

Full text loading...

/content/journals/iadt/10.2174/187152810793938017
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test